BioPharm.Si (Q3270309): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in nl: translated_label) |
(Created claim: summary (P836): Nieuwe generatie biologische geneesmiddelen, translated_summary) |
||||||||||||||
Property / summary | |||||||||||||||
Nieuwe generatie biologische geneesmiddelen (Dutch) | |||||||||||||||
Property / summary: Nieuwe generatie biologische geneesmiddelen (Dutch) / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / summary: Nieuwe generatie biologische geneesmiddelen (Dutch) / qualifier | |||||||||||||||
point in time: 29 November 2021
|
Revision as of 16:44, 29 November 2021
Project Q3270309 in Slovakia
Language | Label | Description | Also known as |
---|---|---|---|
English | BioPharm.Si |
Project Q3270309 in Slovakia |
Statements
4,777,897.3 Euro
0 references
5,972,371.63 Euro
0 references
80.0 percent
0 references
7 July 2016
0 references
31 December 2021
0 references
CO BIK
0 references
0 references
5270
0 references
Nova Generacija bioloških zdravil (Slovenian)
0 references
Identifiers
OP20.00363
0 references